Liu et al. reported that inhibition of ALG3 would induce defects in post-translational N-linked glycosylation modification and lead to excessive lipid accumulation through sterol regulatory element binding proteins (SREBPs)-dependent adipogenesis in cancer cells. This evidence concerns the gene ALG3 and cancer.